1. A phase III clinical trial to evaluate the safety and immunogenicity of 23-valent pneumococcal polysaccharide vaccine (PPV23) in healthy children, adults, and elderly. Issue 1 (2nd January 2019) Authors: Huang, Lili; Wang, Ling; Li, Hong; Hu, Yuansheng; Ru, Weiping; Han, Weixiao; Shi, Gang; Ye, Qiang; Han, Zhen; Xia, Jielai; Xia, Shengli; Xu, Miao; Li, Jing Journal: Human vaccines & immunotherapeutics Issue: Volume 15:Issue 1(2019) Page Start: 249 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗